Overall verdict
Neutral
4.6/10
1-year performance
-82.23%
Score breakdown
Down 82.2% over 1 year, 1% of the 52-week range.
Strongest: Growth 7.8/10. Weakest: Profitability 0.0/10.
13 analysts, target +0.8% vs the price.
Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the healthcare sector in Brazil. It sells health insurance plans through its own clinical, outpatient, and hospital networks, as well as dental plans through an accredited network. Hapvida Participações e Investimentos S.A. was founded in 1979 and is headquartered in Fortaleza, Brazil.
Sector
Health Care
Industry
Health Care Providers and Services
Primary listing
Bmfbovespa
Brazil
CEO
Mr. Luccas Augusto Adib
Founded
1979
Employees
—
Revenue / employee
—
Next earnings
November 11, 2026
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
38.17 BRL
52-week low
6.01 BRL
1-year performance
-82.23%
Declining
Year-to-date performance
-54.95%
Declining
Drawdown
-83.42%
Major drawdown
Position in the 52-week range
1% of range
Gross margin 19.0%, the company loses 0.9% of its revenue, ROIC -0.3%, ROE -0.4%.
Net margin
-0.94%
Negative
Sector 1.68%|S&P 12.97%
Gross margin
18.95%
Fair
Return on equity (ROE)
-0.36%
Negative
Sector 10.87%|S&P 16.52%
Return on invested capital (ROIC)
-0.28%
Negative
Free cash flow margin (FCF)
-5.71%
Negative
Margin stability
3.0 pts
Steady
Revenue to net income
Growth
7.8/10Revenue up 41.3% over 1 year, 29.8% a year over 5.
Revenue (trailing 12 months)
19.5Md BRL
Revenue growth (1y)
41.27%
Hyper-growth
Revenue growth (3y)
32.96%
Solid
EPS growth (1y)
—
EPS CAGR (5y)
—
EPS revisions (3 months)
-47.46%
Sharply revised down
Valuation
6.9/10The company loses money, so no valuation multiple can be read: a negative P/E is not a discount.
P/E (TTM)
—
N/A (loss)
Sector 28.2x|S&P 23.0x
Forward P/E
7.7x
Fair
EV / EBITDA
5.2x
Cheap
Sector 15.7x|S&P 14.5x
PEG
—
Sector 1.49|S&P 0.86
P/E vs its own 5-year history
among the 6% lowest valuations
Far cheaper than usual
Market cap
3.3Md BRL
Financial strength
6.3/10Cash covers 50.8% of the debt, net debt/EBITDA 3.3x.
Net debt / EBITDA
3.3x
Stretched
Gearing (net debt / equity)
15.92%
Very solid
Cash
8.4Md BRL
Cash / market cap
251.63%
Very solid
Cash / total debt
50.76%
Solid
Net debt
8.1Md BRL
Equity
50.9Md BRL
Closed daily candles, 2 years
Last close on September 23, 2026: 6.65 BRL
- MM206.75
- MM508.43
- MM20011.05
- RSI 1441.8
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
-12.76%
200-day average slope, 3 months
-38.99%
50-day average slope, 1 month
-15.58%
Price structure
Lower lows
Bullish RSI divergence
No
20-day volatility
3.57 % per day
Volatility change
-21.57%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | -1.40 (2) | 0.59 (4) | 32 244 (10) | 2 394 (6) | -494 (10) |
| 2027 | 0.82 (4) | 1.10 (6) | 34 007 (13) | 2 924 (12) | 509 (10) |
Amounts in millions of BRL, EPS in BRL per share. In brackets, the number of analysts. Consensus as of September 24, 2026.
Same sub-industry: 10 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SAUD3 | 7.4 | 6.5 | 8.0Md USD | 14.3x | 10.6 % | 1213.1 % | 10.4 % | -0.3x | 1.6 % | 5.3 % | ||
| 2 | HQY | 7.2 | 6.8 | 7.5Md USD | 32.6x | 17.4 % | 7.6 % | 7.7 % | 1.4x | 6.5 % | -5.7 % | ||
| 3 | UNH | 7.1 | 6.3 | 333Md USD | 23.9x | 3.1 % | 0.4 % | 8.4 % | 1.9x | 7.1 % | 7.1 % | ||
| 4 | ELV | 6.6 | 5.6 | 86.4Md USD | 17.7x | 2.5 % | 1.4 % | 6.7 % | — | 7.3 % | 22.7 % | ||
| 5 | CNC | 6.1 | 5.3 | 30.7Md USD | Not meaningful (loss) | -2.5 % | 9.9 % | -12.2 % | 1.5x | 29.2 % | 89.2 % | ||
| 6 | HUM | 5.5 | 4.0 | 45.0Md USD | 35.5x | 0.9 % | 26.2 % | 4.1 % | -1.9x | 4.3 % | 47.6 % | ||
| 7 | CLOV | 5.0 | 4.1 | 2.4Md USD | Not meaningful (loss) | -0.7 % | 55.6 % | -5.1 % | 3.5x | 3.1 % | 38.3 % | ||
| 8 | HAPV3 | 4.6 | 4.8 | 639M USD | Not meaningful (loss) | -0.9 % | 41.3 % | -0.3 % | 3.3x | -33.6 % | -82.2 % | ||
| 9 | MOH | 4.4 | 2.5 | 9.9Md USD | Not meaningful (loss) | -0.0 % | -4.8 % | -0.1 % | -20.7x | 2.7 % | 6.0 % |
